Mardozia Pf (Χωρίσ Συντηρητικό)

Dorzolamide and Timolol, the active ingredients in Mardozia Pf, are a carbonic anhydrase inhibitor and a non‑selective beta‑blocker presented as eye‑drop solution for ocular use. They are employed to lower intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Mardozia Pf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for import. Customers receive batch‑specific certificates of analysis and can request temperature‑controlled shipping where required.

Mardozia Pf combines dorzolamide and timolol to manage conditions that involve elevated intra‑ocular pressure.

- Open‑angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage. - Ocular hypertension: lowers intra‑ocular pressure to prevent progression to glaucoma. - Secondary glaucoma (e.g., pseudoexfoliative): helps control pressure and protect visual function.

Mardozia Pf may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Transient blurred vision. - Bitter taste after administration. - Headache. - Dry eye or reduced tear production. - Mild ocular discomfort.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, rash). - Marked bradycardia or heart block. - Bronchospasm, especially in asthmatic patients. - Systemic hypotension. - Corneal edema or persistent visual loss. - Acute intra‑ocular inflammation.

Before using Mardozia Pf, consider the following safety measures.

- Cardiac assessment: avoid in patients with severe bradycardia or heart block. - Respiratory status: use with caution in asthma or COPD. - Sulfonamide allergy: dorzolamide contains a sulfonamide moiety; contraindicated in known hypersensitivity. - Concomitant beta‑blocker eye drops: avoid combined use to prevent excessive IOP reduction. - Pregnancy and lactation: prescribe only if clearly needed; safety data are limited. - Store at room temperature: keep in the original container, protect from light and moisture.

Mardozia Pf can interact with several systemic and ocular agents.

Major Interactions (Avoid): - Systemic beta‑blockers: additive bradycardia and hypotension. - Non‑selective beta‑blocker inhalers: increased risk of bronchospasm. - Other carbonic anhydrase inhibitors: excessive reduction of aqueous humor. - Topical adrenergic agonists: antagonistic effect on intra‑ocular pressure reduction.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may alter pupil dynamics. - Diuretics: potential electrolyte disturbances. - CYP2D6 inhibitors: may increase timolol plasma concentrations.